Active Ingredient:
Arnica Montana 30X HPUS.
Arnica Montana Tablet
FDA Label NDC 80004-005
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Vitamedica, Inc. for the product Arnica Montana (NDC 80004-005). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient:, purpose:, warnings:, keep out of reach of children:, directions:, indication:, inactive ingredients:, questions:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose:
Anti-Inflammatory
Warnings:
If pregnant or breast-feeding ask a health professional before use. Discontinue use if any adverse reactions occur. Contact your physician, if symptoms do not subside within 14 days.
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if seal is broken or shows any signs of tampering.
Keep Out Of Reach Of Children:
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions:
Adults, three tablets, three times a day. Not intended for children under 12 years of age. This product is a sublingual application.
Indication:
Anti-Inflammatory
Inactive Ingredients:
Copovidone, Crospovidone, Lactose, Magnesium Stearate, Mannitol, Microcrystalline Cellulose, Silicon Dioxide, and Sorbitol.
Questions:
Formulated and Distributed
by VitaMedica Corp.
Henderson, NV 89014
888-367-8605 VitaMedica.com
©2022 VitaMedica Corporation
NDC 80004-005-67
Package Display Label
VitaMedica
Arnica Montana
30X HPUS
REDUCES
Bruising, Swelling & Pain
NATURAL REMEDY
STIMULATES HEALING
Recommended by Plastic Surgeons
Homeopathic Medicine
150 Sublingual Tablets
* Please review the disclaimer below.
